Moderna Inc. requested clearance for its coronavirus vaccine in the U.S. after a new analysis showed it was highly effective in preventing Covid-19, with no serious safety problems.
Moderna Seeks Approval; Possible Early U.S. Spread: Virus Update
More Stories
How to land a good work-from-home job
Pfizer’s COVID-19 vaccine has begun rolling out of its Michigan plant in a truck convoy
Iran Sets Out Ambitions to Hike Oil Production Next Year